Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I

Endocrinology

Volumn 138, Issue 7, 1997, Pages 2972-2978

  Nam, Taek Jeong ^a   Busby Jr , Walker ^a   Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; SOMATOMEDIN BINDING PROTEIN 5;

AMINO ACID SEQUENCE; ARTICLE; BINDING COMPETITION; DISSOCIATION CONSTANT; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN PURIFICATION;

ANIMALS; BINDING SITES; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXTRACELLULAR MATRIX; FIBROBLASTS; GLYCOSAMINOGLYCANS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN BINDING;

EID: 0344358645     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.138.7.2972     Document Type: Article

References (34)

1. Baxter RC, Martin JL 1989 Binding proteins for insulin-like growth factors: structure, regulation and function. Prog Growth Fact Res 1:49-68
2. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
3. Shimasaki S, Shimonaka M, Zhang HP, Ling N 1991 Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP in rat and human. J Biol Chem 266:10646-10653
4. Arai T, Parker AJ, Busby WH, Clemmons DR 1994 Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes. J Biol Chem 269:20358-20393
5. Jones JI, Gockerman A, Busby WH, Camacho-Hubner C, Clemmons DR 1993 Extracellular matrix contains insulin-like growth factor binding protein-5: Potentiation of the effects of IGF-I. J Cell Biol 121:679-687
6. Clemmons DR, Busby Jr WH, Clarke JB, Duan C, Arai T, Nam TJ 1996 Insulin-like growth factor binding proteins and their role in controlling IGF actions. In: LeRoith D (ed) International Symposium on the Role of Insulin-Like Growth Factors in Ovarian Physiology. Rome, Italy: Seromo Symposia Publications, pp 13-24
7. Camacho-Hubner C, Busby WH, McCusker RH, Wright G, Clemmons DR 1992 Identification of the forms of insulin-like growth factor binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J Biol Chem 267:11949-11956
8. Aral T, Arai A, Busby WH, Clemmons DR 1994 Glycosaminoglycans inhibit degradation of insulin-like growth factor binding protein-5. Endocrinology 135:2358-2363
9. Arai T, Clarke S, Parker A, Busby WH, Clemmons DR 1996 Effect of substitution of specific amino acids in insulin-like growth factor binding protein-5 on heparin binding and its change in affinity for IGF-I in response to heparin. J Biol Chem 271:6099-6106
10. Parker A, Busby WH, Clemmons DR 1996 Identification of the extracellular matrix binding site for insulin-like growth factor binding protein-5. J Biol Chem 271:13523-13530
11. Busby WH, Snyder DK, Clemmons DR 1988 Radioimmunoassay of a 26,000 dalton plasma insulin like growth factor binding protein: Control by nutritional variables. J Clin Endocrinol Metab 67:1225-1230
12. Nam TJ, Busby WH, Clemmons DR 1994 Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor binding protein-5. Endocrinology 135:1385-1391
13. Bourner MJ, Busby WH, Siegel NR, Krivi GG, McCusker RH, Clemmons DR 1992 Cloning and sequence determination of bovine insulin-like growth factor binding protein-2 (IGFBP-2): comparison of its structural and functional properties with IGFBP-1. J Cell Biochem 48:215-226
14. Towbin H, Staehelin T, Gordon JI1979 Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sei USA 76:4350-4356
15. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M 19S6 Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154:138-143
16. D'Ercole AJ, Underwood LE, Van Wyk JJ, Decedue CJ, Foushee DB 1976 Specificity topography and ontogeny of the somatomedin C receptor in mammalian tissues. In: Pecile A, Muller R (eds) Growth Hormone and Related Peptides. Amsterdam: Excepta Medica, pp 190-205
17. McCusker RH, Camacho-Hubner C, Clemmons DR 1989 Identification of the types of insulin like growth factor binding proteins that are secreted by muscle cells in vitro. J Biol Chem 264:7795-7800
18. Knutson BS, Haysel PC, Nachman RL 1988 Plasminogen activator is associated with the extracellular matrix of cultured bovine smooth muscle cells. J Clin Invest 80:1082-1088
19. Duan C, Hawes S, Frevelte T, Clemmons DR 1996 Insulin-like growth factor-I (IGF-I) stimulates IGF binding protcin-5 synthesis through transcriptional activation of the gene in aortic smooth muscle cells. J Biol Chem 271:4280-4288
20. Dong Y, Canalis E 1996 Insulin-like growth factor I and retinoic acid induces the synthesis of IGF binding protein 5 in rat ostéoplastie cells. Endocrinology 136:2000-2006
21. Hakeda Y, Kawaguchi H, Hurley M, Pilbeam CC, Abreu C, Linkhardt TA, Mohan S, Kumegawa M, Raisz LG 1996 Intact insulin-like growth factor binding protein-5 (IGFBP-5) associates with bone matrix and the soluble fragments of IGFBP-5 accumulated in cultured medium of neonatal mouse calvariae by parathyroid hormone and prostaglandin E2 treatment. J Cell Physiol 166:370-379
22. Padayalty SJ, Orme S, Zenobi FD, Strickland MH, Belchetz PE, Grant PJ1995 The effects of insulin-like growth factor-I on plasminogen activator inhibitor-l synthesis and secretion: results from in iivo and iu vitro studies. Thromb Haemost 74:1009-1013
23. Anfosso F, Alessi MC, Nalbone G, Chomiki N, Henry N, Juhan-Vague 11995 Upregulated expression of plasminogen activator inhibitor-l in Hep G2 cells: interrelationship between insulin and insulin-like growth factor-I. Thromb Haemost 73:268-274
24. Cockell KA, Ren S, Sun J, Angel A, Shen GX 1995 The effect of thrombin on the release of plasminogen activator inhibitor-l from cultured primate arterial smooth muscle cells. Thromb Res 77:119-131
25. Hagge J, Delarue F, Peraldi MM, Spaer JD, Rondeau E 1994 Heparin selectively inhibits the synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor-l by human mesangial cells. Lab Invest 71:828-83j4
26. Andress DL1995 Heparin modulates the binding of insulin-like growth factor binding protein-5 to a membrane protein in osteoblast cells. J Biol Chem 270:28289-28297
27. Parker A, Busby WH, Clemmons DR 1996 Identification of the extracellular matrix binding site for insulin like growth factor binding protein-5. J Biol Chem 271:13523-13529
28. Jennische E, Skottner A, Hansson HA 1987 Satellite cells express the trophic factor IGF-I in regenerating skeletal muscle. Acta Physiol Scand 129:9-15
29. Jennische E, Skottner A, Hansson HA 1987 Dynamic changes in insulin-like growth factor I immunoreactivity correlate with repair events in rat ear after freeze-thaw injury. Exp Mol Pathol 47:193-201
30. Khachigan LM, Linder V, Williams AJ, Collins T 1996 Egr-1-induced endothelial gene expression: a common theme for vascular injury. Science 271:1427-1430
31. Seiffert D, Loskutoff D 1991 Evidence that type I plasminogen activator inhibitor binds to the somatomedin B domain of vitronectin. J Biol Chem 266:2824-2830
32. van Meijer M, Gebbink RK, Freissner KT, Pannekoek H1994 Determination of vitronectin binding site on plasminogen activator inhibitor-l (PAI-1). FEES Lett 352:342-346
33. Jones JI, Frevelte T, Gockerman A, Clemmons DR 1996 Binding of vitronectin to an aV/33 integrin is necessary for smooth muscle cells to migrate in response to IGF-I. Proc Natl Acad Sei 93:2462-2467
34. Campbell PG, Novak TF, Wines K, Walton PE 1993 Localization of plasmin activity on osteosarcoma cells: cell surface proteolysis of insulin-like growth factor binding proteins. Growth Regul 3:95-98